Clinical trial
A Phase 1 Study of E7090 in Subjects With Solid Tumor
NCT02275910 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of E7090 in Subjects With Solid Tumor
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 28, 2014
- Completion date
- September 3, 2021
- Enrollment
- 40 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
tumors